Trial Profile
Comparison of frequency of dose escalation of infliximab and tociluzumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 03 Jul 2015 New trial record